Health Catalyst, Inc.

NMS: HCAT
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Health Catalyst, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get HCAT Z-Score →

About Health Catalyst, Inc.

Healthcare Health Information Services
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

📊 Fundamental Analysis

Health Catalyst, Inc. demonstrates a profit margin of -57.2%, which is below the sector average, suggesting competitive pressure.

The company recently reported -6.2% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -58.3%, which indicates that capital utilization is currently under pressure.

At a current price of $1.00, HCAT currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $0.95 - $5.06).

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
🔴 Beta (Risk) High Volatility

Key Financials

Market Cap
$73.31M
Trailing P/E
--
Forward P/E
6.29
Beta (5Y)
1.81
52W High
$5.06
52W Low
$0.95
Avg Volume
862K
Day High
Day Low
Get HCAT Z-Score on Dashboard 🚀